CTRI/2024/07/070571Not yet recruitingUnknown
ebulised Budesonide as an adjunct to standard first line therapy for emergency management of moderate to severe acute asthma exacerbations in children aged 2 to 18 years age. - NI
Government Medical College and Hospital Chandigarh0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Children 2 to 18 years of age diagnosed to have an acute exacerbation of asthma. The diagnosis will be based on the following criteria:
- •1.Children aged 2 to 18 years of age presenting to paediatric emergency with acute exacerbation of asthma having Paediatric asthma severity score of 8 to 15
- •2. Is a known case of childhood asthma or past history of at least two similar episodes in last 12 months relieved with bronchodilator therapy or already on controller therapy or with family history of asthma ,atopy ,nebulisations or personal history of atopic dermatitis, food allergy or allergic rhinitis.
Exclusion Criteria
- •1. Presence of signs or symptoms suggestive of pneumonia, tuberculosis, heart disease croup, pertussis, measles, foreign body aspiration.
- •2.Documented fever >38 degrees Celsius
- •3.Life threatening exacerbation attack necessitating PICU admission and/or intubation owing to respiratory failure or depressed consciousness (GCS <8), and/or inotropes
- •4.Children enrolled in any other trial.
- •5.Children previously enrolled in this trial within last one month
- •6.Children who have received systemic corticosteroids for any indication within the previous 4weeks
Investigators
Similar Trials
Recruiting
Phase 2
Safety and efficacy of Budesonide administration after endoscopic balloon dilation for Crohn's disease patients with intestinal stenosisCrohn's diseaseJPRN-jRCT1051190043Takehara Tetsuo15
Completed
Not Applicable
Safety and efficacy of Budesonide administration after endoscopic ballon dilation for Crohn disease patients with intestinal stenosiss diseaseCrohn's diseaseJPRN-UMIN000031839Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology17
Unknown
Phase 3
Investigation of Safety and Efficacy of Budesonide Inhalation Suspension in the Long-Term Use in Japanese Children With Bronchial Asthma (Open Long-Term Extension Study Following Study SD-004-0765AsthmaJPRN-jRCT2080220398AstraZeneca
Recruiting
Not Applicable
Effect of nasal lavage with Budesonide diluted in large volume for the clinical treatment of patients with Chronic Rhinosinusitis with nasal polypsRBR-44h66bClinica Olfact
Not yet recruiting
Not Applicable
Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID casesCTRI/2020/10/028581Dr Tushar Patel